References
  1. Ritz A, Kolorz J, Hubertus J, Ley-Zaporozhan J, Schweinitz DV, Koletzko S, et al. Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma. Pediatr Blood Cancer 2021;e28862.
  2. Lurz E, Patel H, Lebovic G, et al. Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 2020;11:405-14.
  3. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997;127: 990S-991S.
  4. Larsson L, Degens H, Li M, Salviati L, et al. Sarcopenia: Aging-related loss of muscle mass and function. Physiol Rev 2019;99:427-511.
  5. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019;393:2636-46.
  6. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 2010;39:412-23.
  7. Visser M, Schaap LA. Consequences of sarcopenia. Clin Geriatr Med 2011;27:387-99.
  8. Kara M, Kaymak B, Ata AM, et al. STAR - Sonographic thigh adjustment ratio: A Golden formula for the diagnosis of sarcopenia. Am J Phys Med Rehabil 2020;99:902-8.
  9. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 2016;7:512-14.
  10. Wind AE, Takken T, Helders PJ, Engelbert RH. Is grip strength a predictor for total muscle strength in healthy children, adolescents, and young adults? Eur J Pediatr. 2010;169:281-7.